1. Home
  2. BYSI vs TVGN Comparison

BYSI vs TVGN Comparison

Compare BYSI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

HOLD

Current Price

$1.61

Market Cap

67.9M

Sector

Health Care

ML Signal

HOLD

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

HOLD

Current Price

$4.76

Market Cap

63.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYSI
TVGN
Founded
2010
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
67.9M
63.9M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
BYSI
TVGN
Price
$1.61
$4.76
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
22.3K
368.0K
Earning Date
03-25-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.14
52 Week High
$3.44
$10.76

Technical Indicators

Market Signals
Indicator
BYSI
TVGN
Relative Strength Index (RSI) 51.88 59.14
Support Level $1.38 $0.53
Resistance Level $1.83 $10.76
Average True Range (ATR) 0.15 0.73
MACD 0.00 -0.18
Stochastic Oscillator 48.98 2.53

Price Performance

Historical Comparison
BYSI
TVGN

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: